NCT00348790View on ClinicalTrials.gov

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

July 31, 2013

Conditions
Brain and Central Nervous System TumorsSarcoma
Interventions
DRUG

vatalanib

Trial Locations (3)

60611-2998

Hematology-Oncology Associates of Illinois, Chicago

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

98195-6043

University Cancer Center at University of Washington Medical Center, Seattle

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Northwestern University

OTHER